Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Major Depressive Disorder Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00668525
What this trial is testing

Escitalopram in Adult Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Forest Laboratories 877
Large-scale testing (Phase 3)Study completedNCT01188135
What this trial is testing

Antidepressant Adherence Via AD_IVR

Who this might be right for
Major Depressive Disorder
Kaiser Permanente 6,058
Post-approval studies (Phase 4)Study completedNCT00437125
What this trial is testing

Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease

Who this might be right for
Major Depressive DisorderIdiopathic Parkinson Disease
Eli Lilly and Company 151
Not applicableStudy completedNCT00616889
What this trial is testing

Effect of Quetiapine on Sleep Architecture in Bipolar Depression and Major Depressive Disorder

Who this might be right for
Bipolar Disorder
Queen's University 15
Not applicableLooking for participantsNCT06234176
What this trial is testing

Impact of Psychomotor Therapy on the Quality of Life in Depression

Who this might be right for
Major Depressive Disorder
Centre Hospitalier Esquirol 128
Not applicableLooking for participantsNCT05866991
What this trial is testing

Cohort of Patients Suffering From Major Depressive Episode With Evaluation of Sleep, Circadian Rhythms and Psychiatric Disorders

Who this might be right for
Major Depressive Episode
Assistance Publique - Hôpitaux de Paris 1,000
Large-scale testing (Phase 3)Ended earlyNCT01363310
What this trial is testing

The Quietude Study: Quetiapine Use for Agitated Depression

Who this might be right for
Depression With Prominent Agitation
Physicians Research And Education Network 250
Testing effectiveness (Phase 2)Study completedNCT00166296
What this trial is testing

Efficacy and Safety of Escitalopram for Prevention of Depression Induced by Peg-Interferon in Hepatitis C Patients

Who this might be right for
Major Depressive DisorderHepatitis C, Chronic
Germans Trias i Pujol Hospital 133
Large-scale testing (Phase 3)Study completedNCT03113968
What this trial is testing

ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD)

Who this might be right for
Treatment Resistant DepressionElectroconvulsive TherapyECT+6 more
Bo Hu 403
Testing effectiveness (Phase 2)WithdrawnNCT05991232
What this trial is testing

Repeated Neurocognitive Measurements in Depressed Patients

Who this might be right for
Depression, Unipolar
Jay Fournier
Post-approval studies (Phase 4)Study completedNCT00474708
What this trial is testing

Study Comparing the Efficacy of Venlafaxine XR Vs. SSRIs and Conventional Antidepressants in Depressed Patients

Who this might be right for
Major Depressive Disorder
Wyeth is now a wholly owned subsidiary of Pfizer 1,151
Testing effectiveness (Phase 2)Study completedNCT03193398
What this trial is testing

BTRX-246040 Administered Once Daily to Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
BlackThorn Therapeutics, Inc. 104
Not applicableStudy completedNCT02773108
What this trial is testing

Somatic Comorbidities in Psychiatric Patients

Who this might be right for
SchizophreniaMajor Depression DisorderBipolar Affective Disorder
Sveti Ivan Psychiatric Hospital 1,061
Post-approval studies (Phase 4)Ended earlyNCT01066897
What this trial is testing

Imaging the Nucleus Accumbens in Major Depressed Patients 'Treated With Pramipexole

Who this might be right for
Depression
Stanford University 16
Not applicableLooking for participantsNCT04806620
What this trial is testing

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

Who this might be right for
Post-Acute COVID-19 SyndromeME/CFSRheumatic Arthritis+41 more
Brain Inflammation Collaborative 10,000
Not applicableStudy completedNCT04770454
What this trial is testing

Evaluate the Quality of Life and Treatment of Anxiety Symptoms of Buspirone in Patients With Depression Disorders(BASIS)

Who this might be right for
Depressive Disorder, MajorAnxiety Disorders
Boryung Pharmaceutical Co., Ltd 200
Not applicableEnrolling By InvitationNCT07314190
What this trial is testing

Retrospective Observational Study of Blood-based Biomarkers in the Diagnosis and Monitoring of Patients With a Neurodegenerative Disease or Mental Disorder

Who this might be right for
Alzheimer DiseaseDementia With Lewy Bodies (DLB)Frontotemporal Dementia (FTD)+4 more
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 1,799
Testing effectiveness (Phase 2)Study completedNCT02458690
What this trial is testing

EIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed Patients

Who this might be right for
DepressionMajor Depressive DisorderDysthymic Disorder+5 more
Indiana University 216
Not applicableEnded earlyNCT02422303
What this trial is testing

Effects of Low Dose Ketamine Given at Induction of Anesthesia on Postoperative Mood in Patients With Depressive Symptoms

Who this might be right for
DepressionMajor Depressive Disorder
The University of Texas Health Science Center at San Antonio 12
Post-approval studies (Phase 4)Study completedNCT00422162
What this trial is testing

A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression

Who this might be right for
Major Depressive Disorder
Eli Lilly and Company 339
Next Page